Evexia Lifecare Ltd to acquire 80% stake in Revin Labs Pvt Ltd

The Board of Directors of Evexia Lifecare Limited in their Board Meeting held today i.e. April 24, 2024 at the Registered office of the company approved the acquisition/purchase of 80% stake in Revin Labs Private Limited which is into Analytical Testing Services to Pharmaceuticals and aTesting of drugs in its Certified Laboratory, for consideration of Rs. 44.80 crores.

Currently, the Issued and Paid up capital of the Company is Rs. 4,00,00,000 divided into 40,00,000 equity shares of Rs. 10 each. Hence, the Company will be acquiring 32,00,000 equity shares of Rs. 10 each at the issue price of Rs. 140 each (including premium amount of Rs. 130/- per share)

It is to be further noted that the amongst 44.80 crore, 50% amount shall cash consideration and the remaining 50% amount shall be adjusted by issuing equity shares of Evexia Lifecare Limited to the individual shareholders of Revin Labs Private Limited, subject to requisite approvals.

Source : Equity Bulls

Keywords

EvexiaLifecare Acquisition RevinLabs